|
|
H2021/CTD8692/20203EUA
|
COVID-19 VACCINE JANSSEN (AD26.COV2-S [RECOMBINANT])
|
COVID-19 VACCINE (AD26.COV2-S [RECOMBINANT])
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Revoked
|
Details →
|
|
|
H2026/CTD13197/26053
|
STELARA 130MG CONCENTRATE FOR SOLUTION FOR INFUSION
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
3295
|
MOTILIUM SUSPENSION
|
DOMPERIDONE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2018/4238/275ER
|
SIMPONI 50MG
|
GOLIMUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2018/4238/275ER/R1
|
Simponi 50mg Pre filled Syringe
|
Golimumab
|
Janssen Biologics B.V
|
Retained
|
Details →
|
|
|
7044
|
SPORANOX 100 MG
|
ITRACONAZOLE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2026/CTD13196/26051
|
STELARA 45MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2026/CTD13195/26052
|
STELARA 90MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
|
USTEKINUMAB
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
7136
|
STUGERON
|
CINNARIZINE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
818
|
DAKTACORT CREAM
|
MICONAZOLE NITRATE AND HYDROCORTISONE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2018/CTD3874/181ER
|
BENYLIN WET COUGH MENTHOL
|
GUAIFENESIN
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
3293
|
MOTILIUM TABLETS
|
DOMPERIDONE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
12822
|
RISPERDAL 2
|
RISPERIDONE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2001/0007/12822/R1
|
RISPERDAL 2
|
RISPERIDONE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
5506
|
NIZORAL CREAM
|
KETOCONAZOLE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2016/CTD 2473/273
|
CONCERTA 18MG
|
METHYLPHENIDATE HYDROCHLORIDE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2016/CTD 2475/276
|
CONCERTA 27MG
|
METHYLPHENIDATE HYDROCHLORIDE
|
JOHNSON & JOHNSON MIDDLE EAST FZ LLC
|
Registered
|
Details →
|
|
|
H2016/CTD 2475/276/R1
|
Concerta 27mg extended-release tablet
|
Methylphenidate Hydrochloride
|
Janssen Pharmaceuticals, Inc
|
Retained
|
Details →
|
|
|
H2016/CTD2475/276/R1
|
Concerta 27mg extended-release tablet
|
Methylphenidate Hydrochloride
|
Janssen Pharmaceuticals, Inc
|
Retained
|
Details →
|
|
|
H2016/CTD 2476/275/R1
|
Concerta 36mg extended-release tablet
|
methylphenidate hydrochloride
|
Janssen Pharmaceuticals, Inc
|
Retained
|
Details →
|